Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction.

Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation (2015) 2.16

Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol (2014) 1.92

Sex-related differences in access to care among patients with premature acute coronary syndrome. CMAJ (2014) 1.67

Carotid endarterectomy national trends over a decade: does sex matter? Ann Vasc Surg (2013) 1.41

Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. Eur Heart J Acute Cardiovasc Care (2013) 1.12

[Delays in the management of acute coronary syndromes with ST-ST segment elevation in Ouagadougou and factors associated with an extension of these delays: a cross-sectional study about 43 cases collected in the CHU-Yalgado Ouédraogo]. Pan Afr Med J (2012) 0.85

Rates and timing of central venous cannulation among patients with sepsis and respiratory arrest admitted by the emergency department*. Crit Care Med (2014) 0.85

Revisiting Mars and Venus: understanding gender differences in critical illness. Crit Care (2011) 0.80

Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Heart (2015) 0.79

Performance of reperfusion therapy and hospital mortality in ST-elevation myocardial infarction patients with non-chest pain complaints. Yonsei Med J (2014) 0.78

Symptoms and delay times during myocardial infarction in 694 patients with and without diabetes; an explorative cross-sectional study. BMC Cardiovasc Disord (2016) 0.75

Impact of Sex and Contact-to-Device Time on Clinical Outcomes in Acute ST-Segment Elevation Myocardial Infarction-Findings From the National Cardiovascular Data Registry. J Am Heart Assoc (2017) 0.75

Sex and Outcomes After Percutaneous Coronary Intervention: A Cause for Concern for Young Women and Those With ST-Segment Elevation Myocardial Infarction? J Am Heart Assoc (2017) 0.75

[Gender aspects in cardiovascular diseases]. Z Gerontol Geriatr (2013) 0.75

Universal definition of myocardial infarction. Circulation (2007) 11.69

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Third universal definition of myocardial infarction. Circulation (2012) 8.47

Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98

Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83

Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med (2013) 6.01

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation (2007) 5.56

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49

Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation (2003) 4.43

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation (2007) 3.62

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med (2003) 3.43

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J (2006) 3.14

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA (2007) 2.99

Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA (2004) 2.89

Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 2.82

BIPHASIC Trial: a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest. Circulation (2007) 2.80

International variation in and factors associated with hospital readmission after myocardial infarction. JAMA (2012) 2.75

Neural correlates of individual ratings of emotional salience: a trial-related fMRI study. Neuroimage (2004) 2.66

Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA (2006) 2.53

Aging and the neural correlates of successful picture encoding: frontal activations compensate for decreased medial-temporal activity. J Cogn Neurosci (2005) 2.52

Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ (2005) 2.50

Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (2009) 2.49

International differences in evolution of early discharge after acute myocardial infarction. Lancet (2004) 2.47

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation (2007) 2.42

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation (2007) 2.30

Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J (2006) 2.26

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet (2013) 2.22

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA (2012) 2.22

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation (2008) 2.19

Sex differences in mortality following acute coronary syndromes. JAMA (2009) 2.17

Medial frontal cortex activity and loss-related responses to errors. J Neurosci (2006) 2.15

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation (2003) 2.09

The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events. Am J Med (2002) 2.09

Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05

Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol (2013) 1.95

Neural correlates of social and nonsocial emotions: An fMRI study. Neuroimage (2006) 1.82

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA (2009) 1.80

Better outcomes for patients treated at hospitals that participate in clinical trials. Arch Intern Med (2008) 1.77

Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry (2005) 1.75

Evaluating research in cardiovascular medicine: citation counts are not sufficient. Circulation (2011) 1.73

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation (2003) 1.72

Cardiology and emergency medicine: united we stand, divided we fall. Ann Emerg Med (2002) 1.72

Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail (2008) 1.68

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J Am Coll Cardiol (2006) 1.64

Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur Heart J (2009) 1.61

Do the investigative sites that take part in a positive clinical trial translate that evidence into practice? Am J Med (2002) 1.60

Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone. Am J Cardiol (2002) 1.60

Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial. Am Heart J (2011) 1.58

Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. J Am Coll Cardiol (2005) 1.58

Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder. J Psychiatry Neurosci (2012) 1.58

A functional neuroimaging study of motivation and executive function. Neuroimage (2004) 1.57

Neural dysregulation in posttraumatic stress disorder: evidence for disrupted equilibrium between salience and default mode brain networks. Psychosom Med (2012) 1.57

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med (2009) 1.56

Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. J Am Coll Cardiol (2012) 1.56

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial. Eur Heart J (2013) 1.56

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail (2004) 1.54

Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint. Eur Heart J (2012) 1.53

The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med (2013) 1.52

Does fitness level modulate the cardiovascular hemodynamic response to exercise? J Appl Physiol (1985) (2006) 1.51

Reflecting on governance for CMAJ. CMAJ (2006) 1.49

From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol (2003) 1.47

Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging (2010) 1.47

Intra-pulmonary shunt and pulmonary gas exchange during exercise in humans. J Physiol (2004) 1.46

Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial. Circulation (2011) 1.46

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J (2012) 1.45

How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J (2005) 1.45

Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial. CMAJ (2012) 1.45

Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon? Int J Cardiol (2007) 1.45

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. J Am Coll Cardiol (2003) 1.44

Do cardiac troponins provide prognostic insight in hemodialysis patients? Can J Cardiol (2003) 1.43

Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial. Am Heart J (2010) 1.43

Acute heart failure: perspectives from a randomized trial and a simultaneous registry. Circ Heart Fail (2012) 1.42

Public sensationalism and clinical trials: how to address the challenges of science? Am J Med (2010) 1.42

Neural correlates of message tailoring and self-relatedness in smoking cessation programming. Biol Psychiatry (2008) 1.41

Editorial independence for CMAJ: signposts along the road. CMAJ (2006) 1.41

Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging (2006) 1.40

Altered amygdala resting-state functional connectivity in post-traumatic stress disorder. Front Psychiatry (2011) 1.39

Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit. CMAJ (2003) 1.39

Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial. Am Heart J (2006) 1.38

The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination. JACC Cardiovasc Interv (2011) 1.38

A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol (2006) 1.37

Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J (2010) 1.36

Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. JACC Cardiovasc Interv (2009) 1.35

Sharing Data from Cardiovascular Clinical Trials - A Proposal. N Engl J Med (2016) 1.34

The birth of the Canadian Academy of Health Sciences. Clin Invest Med (2005) 1.33

Cultural differences in neural function associated with object processing. Cogn Affect Behav Neurosci (2006) 1.32

Working memory for complex scenes: age differences in frontal and hippocampal activations. J Cogn Neurosci (2003) 1.32

Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol (2009) 1.30

Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv (2013) 1.30